Gastrointestinal Cancer

Posted On 2020-06-03 09:05:12

Globally, gastroesophageal adenocarcinomas (GEAs) impose an enormous health burden. In most of the world, diagnosis is made based on symptoms and not potential risk. This leads to high number of cases with advanced cancer at diagnosis. Advanced GEA patients face especial challenges such as nutritional deficiency, anemia, low-grade chronic bleeding, peritoneal carcinomatosis, and ovarian metastases (in females) in conjunction with lack of effective therapeutic options.

Impediments to therapeutic advances for patients with gastroesophageal adenocarcinoma

Jaffer A. Ajani

Review Article
Molecular biology and immunology of gastric cancer peritoneal metastasis
Xiaodan Yao, Jaffer A. Ajani, Shumei Song

Diffuse gastric cancer: histologic, molecular, and genetic basis of disease
Pritish Iyer, Maitham Moslim, Jeffrey M. Farma, Crystal S. Denlinger

Next generation sequencing in gastric or gastroesophageal adenocarcinoma
Geoffrey Y. Ku

Systemic therapy for advanced gastroesophageal cancers: progress and pitfalls
Raisa J. Epistola, Joseph Chao

Shifting sands: the role of radiotherapy for patients with gastric and gastroesophageal adeno-carcinoma
Ethan B. Ludmir, Prajnan Das

Gastrointestinal cancers: current biomarkers in esophageal and gastric adenocarcinoma
Purabi Dhakras, Nataliya Uboha, Vanessa Horner, Erica Reinig, Kristina A. Matkowskyj

Advances in the surgical management of gastric and gastroesophageal junction cancer
Raja R. Narayan, George A. Poultsides

The series “Gastrointestinal Cancer” was commissioned by the editorial office, Translational Gastroenterology and Hepatology without any sponsorship or funding. Jaffer A. Ajani served as the unpaid Guest Editor for the series.